Respiratory infections caused by non-typeable Haemophilus influenzae

Current Opinion in Infectious Diseases

Volumn 16, Issue 2, 2003, Pages 129-134

  Murphy, Timothy F ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

Author keywords

Antimicrobial susceptibility; Chronic obstructive pulmonary disease; Haemophilus influenzae; Immune response; Nasopharyngeal colonization; Non typeable Haemophilus influenzae; Otitis media; Outer membrane protein; Respiratory tract infection

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; HAEMOPHILUS INFLUENZAE VACCINE; MACROLIDE; OLIGOSACCHARIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VIRULENCE FACTOR;

ADULT; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; BIOFILM; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; HAEMOPHILUS INFLUENZAE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; INFANT; LOWER RESPIRATORY TRACT INFECTION; NONHUMAN; OTITIS MEDIA; PATHOGENESIS; PNEUMONIA; RESPIRATORY TRACT INFECTION; REVIEW; SINUSITIS;

EID: 0037397842     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200304000-00009     Document Type: Review

References (77)

1. Sethi S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000. A state of the art review. Clin Microbiol Rev 2001; 14:336-363.
2. Mylotte JM. Nursing home-acquired pneumonia. Clin Infect Dis 2002; 35:1205-1211. This provides an excellent overview of nursing home acquired pneumonia.
3. Bartlett JG, Breiman RF, Mandell LA, et al. Community-acquired pneumonia in adults: Guidelines for management. Clin Infect Dis 1998; 26:811-838.
4. Pelton SI. Acute otitis media in an era of increasing antimicrobial resistance and universal administration of pneumococcal conjugate vaccine. Pediatr Infect Dis J 2002; 21:599-604; discussion 613-4. This paper reviews practical issues of antibiotic choice for acute otitis media.
5. Turner D, Leibovitz E, Aran A, et al. Acute otitis media in infants younger than two months of age: microbiology, clinical presentation and therapeutic approach. Pediatr Infect Dis J 2002; 21:669-674. This study utilizing tympanocentesis shows that the bacteriology of acute otitis media in younger infants is similar to that in older children and that antibiotic resistance appears early.
6. Block SL, Hedrick JA, Tyler RD, et al. Microbiology of acute otitis media recently treated with aminopenicillins. Pediatr Infect Dis J 2001; 20:1017-1021. This paper shows that the predominant organism recovered from middle ear fluid from children recently treated with amoxicillin/clavulanate was H. influenzae.
7. Karlidag T, Demirdag K, Kaygusuz I, et al. Resistant bacteria in the adenoid tissues of children with otitis media with effusion. Int J Pediatr Otorhinolaryngol 2002; 64:35-40.
8. Hoberman A, Marchant CD, Kaplan SL, et al. Treatment of acute otitis media consensus recommendations. Clin Pediatr (Phila) 2002; 41:373-390. This paper provides consensus recommendations by a panel of expert clinicians for the management of acute otitis media.
9. Ghaffar F, Muniz LS, Katz K, et al. Effects of large dosages of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae. Haemophilus influenzae, nonpneumococcal alpha-hemolytic streptococci, and Staphylococcus aureus in children with acute otitis media. Clin Infect Dis 2002; 34:1301-1309. This interesting study showed that different antibiotics have different effects on nasopharyngeal colonization by H. influenzae and other respiratory tract bacterial flora.
10. Berkovitch M, Bulkowstein M, Zhovtis D, et al. Colonization rate of bacteria in the throat of healthy infants. Int J Pediatr Otorhinolaryngol 2002; 63:19-24.
11. Marchisio P, Gironi S, Esposito S, et al. Seasonal variations in nasopharyngeal carriage of respiratory pathogens in healthy Italian children attending day-care centres or schools. J Med Microbiol 2001; 50:1095-1099.
12. Das BK, Arora NK, Mathur P, et al. Nasopharyngeal carriage of Haemophilus influenzae. Indian J Pediatr 2002; 69:775-777.
13. Harabuchi Y, Kodama H, Faden H. Outcome of acute otitis media and its relation to clinical features and nasopharyngeal colonization at the time of diagnosis. Acta Otolaryngol 2001; 121:908-914. This study showed that the course of acute otitis media might be predicted at the time of diagnosis in part by careful clinical evaluation and knowledge of bacterial pathogens in the nasopharynx.
14. Lindberg K, Gustafson R, Samuelson A, et al. Impact of IgG replacement therapy and antibiotic treatment on the colonization of non-encapsulated Haemophilus influenzae in the nasopharynx in patients with hypogammaglobulinaemia. Scand J Infect Dis 2001; 33:904-908.
15. Smith-Vaughan HC, McBroom J, Mathews JD. Modelling of endemic carriage of Haemophilus influenzae in Aboriginal infants in Northern Australia. FEMS Immunol Med Microbiol 2001; 31:137-143.
16. Munson E, Pfaller M, Koontz F, Doern G. Comparison of porphyrin-based, growth factor-based, and biochemical-based testing methods for identification of Haemophilus influenzae. Eur J Clin Microbiol Infect Dis 2002; 21:196-203. This rigorous evaluation of laboratory methods to confirm the identity of an isolate as H. influenzae showed that porphyrin-based methods are the most accurate.
17. Peerbooms PG, Engelen MN, Stokman DA, et al. Nasopharyngeal carriage of potential bacterial pathogens related to day care attendance, with special reference to the molecular epidemiology of Haemophilus influenzae. J Clin Microbiol 2002; 40:2832-2836. This study showed that nasopharyngeal colonization of children by H. influenzae is a dynamic process and that frequent transmission of the organism occurs in day care centers.
18. Post JC, Preston RA, Aul JJ, et al. Molecular analysis of bacterial pathogens in otitis media with effusion. JAMA 1995; 273:1598-1604.
19. Ueyama T, Kurono Y, Shirabe K, et al. High incidence of Haemophilus influenzae in nasopharyngeal secretions and middle ear effusions as detected by PCR. J Clin Microbiol 1995; 33:1835-1838.
20. Post JC, Aul JJ, White GJ et al. PCR-based detection of bacterial DNA after antimicrobial treatment is indicative of persistent, viable bacteria in the chinchilla model of otitis media. Am J Otolaryngol 1996; 17:106-111.
21. Murphy TF, Kirkham C. Biofilm formation by non-typeable Haemophilus influenzae: strain variability, outer membrane antigen expression and role of pill. BMC Microbiol 2002; 2:7-14. This paper shows that clinical isolates of non-typeable H. influenzae show substantial variability in their ability to grow as biofilms.
22. Ehrlich GD, Veeh R, Wang X et al. Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. JAMA 2002; 287:1710-1715. This study demonstrated that H. influenzae forms biofilms in the middle ear of chinchillas during experimental infection.
23. Post JC. Direct evidence of bacterial biofilms in otitis media. Laryngoscope 2001; 111:2083-2094. Biofilms were visually detected on tympanostomy tubes removed from children, supporting the concept that bacteria grow as biofilms in the middle ear.
24. Finegold SM, Flynn MJ, Rose FV, et al. Bacteriologic findings associated with chronic bacterial maxillary sinusitis in adults. Clin Infect Dis 2002; 35:428-433.
25. Brook I. Bacteriology of acute and chronic frontal sinusitis. Arch Otolaryngol Head Neck Surg 2002; 128:583-585.
26. Talbot GH, Kennedy DW, Scheld WM, et al. Rigid nasal endoscopy versus sinus puncture and aspiration for microbiologic documentation of acute bacterial maxillary sinusitis. Clin Infect Dis 2001; 33:1666-1675.
27. Conrad DA, Jenson HB. Management of acute bacterial rhinosinusitis. Curr Opin Pediatr 2002; 14:86-90.
28. Fendrick AM, Saint S, Brook I, et al. Diagnosis and treatment of upper respiratory tract infections in the primary care setting. Clin Ther 2001; 23:1683-1706.
29. Murphy TF, Sethi S. Chronic obstructive pulmonary disease: role of bacteria and guide to antibacterial selection in the older patient. Drugs Aging 2002; 19:761-775. This is a comprehensive review of factors for the clinician to consider in deciding which patients with exacerbations of COPD to treat with antibiotics and the choice of antibiotic.
30. Nouira S, Marghli S, Belghith M, et al. Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo- controlled trial. Lancet 2001; 358:2020-2025. This was a well done randomized, prospective, placebo controlled trial showing that treatment of severe exacerbations of COPD with a fluoroquinolone resulted in reduction in mortality, duration of mechanical ventilation and duration of hospital stay.
31. Sethi S, Evans N, Grant BJB, et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002; 347:465-471. This prospective study showed that acquisition of a new strain of H. influenzae, Moraxella catarrhalis or Streptococcus pneumoniae was associated with an increased risk of exacerbation, supporting the causative role of bacteria in exacerbations of COPD.
32. Patel IS, Seemungal TA, Wilks M, et al. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002; 57:759-764. This study demonstrated that airway colonization by bacteria in the clinically stable state was associated with increased frequency and severity of exacerbations.
33. Bandi V, Apicella MA, Mason E, et al. Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med 2001; 164:2114-2119. This study involving analysis of samples obtained by the protected specimen brush showed a high frequency of intracellular H. influenzae during exacerbations of COPD, even when the organism was not present in cultures of expectorated sputum.
34. Craig JE, Cliffe A, Garnett K, et al. Survival of nontypeable Haemophilus influenzae in macrophages. FEMS Microbiol Lett 2001; 203:55-61.
35. King PT, Hutchinson PE, Johnson PD, et al. Adaptive immunity to nontypeable Haemophilus influenzae. Am J Respir Crit Care Med 2002; 14 [epub ahead of print]. This intriguing study showed that adults with bronchiectasis and healthy controls had different immune responses to H. influenzae antigens, suggesting that the immune response to H. influenzae may be important in the pathogenesis of bronchial infection.
36. Abe Y, Murphy TF, Sethi S, et al. Lymphocyte proliferative response to P6 of Haemophilus influenzae is associated with relative protection from exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 165:967-971. This paper describes the first identification of a specific antigen of H. influenzae as a target of a potentially protective human immune response in COPD.
37. Stratchounski LS, Kretchikova OI, Reshedko GK, et al. Antimicrobial susceptibility of nasopharyngeal isolates of Haemophilus influenzae from healthy children in day-care centres: results of multicentre study in Russia. Int J Antimicrob Agents 2001; 18:347-351.
38. Casagrande ST, Landgraf IM, Kobata AM, et al. Antimicrobial resistance among invasive Haemophilus influenzae strains: results of a Brazilian study carried out from 1996 through 2000. Braz J Med Biol Res 2002; 35:1293-1300.
39. Turnak MR, Bandak SI, Bouchillon SK, et al. Antimicrobial susceptibilities of clinical isolates of Haemophilus influenzae and Moraxella catarrhalis collected during 1999-2000 from 13 countries. Clin Microbiol Infect 2001; 7:671-677. This multicenter study showed that more than 20% of 2712 strains of H. influenzae were resistant to ampicillin and trimethoprim/sulfamethoxasole.
40. Jones ME, Karlowsky JA, Blosser-Middleton R, et al. Apparent plateau in beta-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the LIBRA Surveillance initiative. Int J Antimicrob Agents 2002; 19:119-123. This study of 2791 strains of H. influenzae showed the antimicrobial susceptibility and prevalence of β-lactamase production remained unchanged from 1997 to 1999 in the US.
41. Thornsberry C, Sahm DF, Kelly LJ, et al. Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000. Clin Infect Dis 2002; 34 (suppl 1):S4-S16. This study of 1934 isolates of H. influenzae showed substantial variation in regional antimicrobial resistance rates and β-lactamase production throughout the US.
42. Marco F, Garcia-de-Lomas J, Garcia-Rey C, et al. Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1996-1999. Antimicrob Agents Chemother 2001; 45:3226-3228.
43. Debbia EA, Schito GC, Zoratti A, et al. Epidemiology of major respiratory pathogens. J Chemother 2001; 13:205-210.
44. Karlowsky JA, Critcley IA, Blosser-Middleton RS, et al. Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a beta-lactamase-negative and ampicillin-resistant strain. J Clin Microbiol 2002; 40:1063-1066.
45. Dabernat H, Delmas C, Seguy M, et al. Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother 2002; 46:2208-2218.
46. Hu YY, Yu SJ, Liu G, et al. Antimicrobial susceptibility of Haemophilus influenzae among children in Beijing, China, 1999-2000. Acta Paediatr 2002; 91:136-140.
47. St Geme JW. Molecular and cellular determinants of non-typeable Haemophilus influenzae adherence and invasion. Cell Microbiol 2002; 4:191-200. This is an excellent review of mechanisms of adherence and invasion of the respiratory tract by non-typeable H. influenzae.
48. Fink DL, Green BA, St Geme JW 3rd. The Haemophilus influenzae Hap autotransporter binds to fibronectin, laminin, and collagen IV. infect Immun 2002; 70:4902-4907. This paper suggests that interactions between an adhesin of H. influenzae and host extracellular matrix proteins play a role in colonization of the respiratory tract.
49. Eberhard T, Ullberg M. Interaction of vitronectin with Haemophilus influenzae. FEMS Immunol Med Microbiol 2002; 34:215-219. This study demonstrates a highly specific interaction between vitronectin and H. influenzae.
50. van Ulsen P, van Schilfgaarde M, Dankert J, et al. Genes of non-typeable Haemophilus influenzae expressed during interaction with human epithelial cell lines. Mol Microbiol 2002; 45:485-500. The identification of six different functional classes of genes expressed by H. influenzae during interaction with human respiratory cell lines will be important in elucidating adaptation of the bacterium to the epithelial cell environment.
51. Jono H, Shuto T, Xu H, et al. Transforming growth factor-beta-Smad signaling pathway cooperates with NF-kappa B to mediate nontypeable Haemophilus influenzae-induced MUC2 mucin transcription. J Biol Chem 2002; 277:45547-45557. This study was the first to demonstrate the involvement of TGF-beta receptor-mediated signaling in bacteria-induced upregulation of mucin transcription and may lead to novel methods to interrupt colonization or infection by H. influenzae.
52. Shuto T, Xu H, Wang B, et al. Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha/beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc Natl Acad Sci U S A 2001; 98:8774-8779. This work shows that the P6 protein of H. influenzae activates NF kappa B, a transcriptional activator of multiple host defense genes involved in immune and inflammatory responses.
53. Wang B, Lim DJ, Hart J, et al. Novel cytoplasmic proteins of nontypeable Haemophilus influenzae up-regulate human MUC5AC mucin transcription via a positive p38 mitogen- activated protein kinase pathway and a negative phosphoinositide 3-kinase-Akt pathway. J Biol Chem 2002; 277:949-957. These results demonstrate a role for cytoplasmic molecules from lysed H. influenzae in the upregulation of mucin production, a potentially important mechanism of pathogenesis in otitis media and COPD.
54. Jones PA, Samuels NM, Phillips NJ, et al. Haemophilus influenzae type b strain A2 has multiple sialyltransferases involved in lipooligosaccharide sialylation. J Biol Chem 2002; 277:14598-14611. This paper shows that sialylation of the lipooligosaccharide of H. influenzae involves multiple sialyltransferases, an important observation to elucidate the role of sialylation in host pathogen interactions.
55. Bauer SH, Mansson M, Hood DW, et al. A rapid and sensitive procedure for determination of 5-N-acetyl neuraminic acid in lipopolysaccharides of Haemophilus influenzae: a survey of 24 non-typeable H. influenzae strains. Carbohydr Res 2001; 335:251-260.
56. Fan X, Goldfine H, Lysenko E, et al. The transfer of choline from the host to the bacterial cell surface requires glpQ in Haemophilus influenzae. Mol Microbiol 2001; 41:1029-1036. This study identified an enzyme that allows adherent H. influenzae to obtain choline to be transferred from the host to the bacterial cell surface.
57. Cox AD, Hood DW, Martin A, et al. Identification and structural characterization of a sialylated lacto-N- neotetraose structure in the lipopolysaccharide of Haemophilus influenzae. Eur J Biochem 2002; 269:4009-4019.
58. Shao J, Zhang J, Kowal P, et al. Overexpression and biochemical characterization of beta-1,3-N-acetylgalactosaminyltransferase LgtD from Haemophilus influenzae strain Rd. Biochem Biophys Res Commun 2002; 295:1-8.
59. Li J, Bauer SH, Mansson M, et al. Glycine is a common substituent of the inner core in Haemophilus influenzae lipopolysaccharide. Glycobiology 2001; 11:1009-1015.
60. Cox AD, Masoud H, Thibault P, et al. Structural analysis of the lipopolysaccharide from the nontypable Haemophilus influenzae strain SB 33. Eur J Biochem 2001; 268:5278-5286.
61. Mansson M, Hood DW, Li J, et al. Structural analysis of the lipopolysaccharide from nontypeable Haemophilus influenzae strain 1003. Eur J Biochem 2002; 269:808-818.
62. Schweda EK, Li J, Moxon ER, et al. Structural analysis of lipopolysaccharide oligosaccharide epitopes expressed by non-typeable Haemophilus influenzae strain 176. Carbohydr Res 2002; 337:409-420.
63. Swords WE, Chance DL, Cohn LA, et al. Acylation of the lipooligosaccharide of Haemophilus influenzae and colonization: an htrB mutation diminishes the colonization of human airway epithelial cells. Infect Immun 2002; 70:4661-4668. These results implicate acylation of H. influenzae lipid A as playing a key role in colonization of the human respiratory tract.
64. Starner TD, Swords WE, Apicella MA, et al. Susceptibility of nontypeable Haemophilus influenzae to human beta- defensins is influenced by lipooligosaccharide acylation. Infect Immun 2002; 70:5287-5289.
65. Pettigrew MM, Foxman B, Marrs CF, et al. Identification of the lipooligosaccharide biosynthesis gene lic2B as a putative virulence factor in strains of nontypeable Haemophilus influenzae that cause otitis media. Infect Immun 2002; 70:3551-3556. This paper identified a lipooligosacchride synthesis gene as a virulence factor for H. influenzae strains that cause otitis media. It is one of the first studies that distinguishes disease-causing strains from commensal strains of nontypeable H. influenzae.
66. Shurin PA, Pelton SI, Tazer IB, et al. Bactericidal antibody and susceptibility to otitis media caused by nontypeable strains of Haemophilus influenzae. J Pediatr 1980; 97:364-369.
67. Faden H, Bernstein J, Brodsky L, et al. Otitis media in children. I. The systemic immune response to nontypable Haemophilus influenzae. J Infect Dis 1989; 160:999-1004.
68. Cutter D, Mason KW, Howell AP, et al. Immunization with Haemophilus influenzae Hap adhesin protects against nasopharyngeal colonization in experimental mice. J Infect Dis 2002; 186:1115-1121. This study shows that intranasal immunization with Hap adhesin reduced the density of nasopharyngeal colonization following challenge with H. influenzae, suggesting Hap may represent an effective mucosal vaccine antigen.
69. Bakaletz LO. Peptide and recombinant antigens for protection against bacterial middle ear infection. Vaccine 2001; 19:2323-2328. This paper shows protective responses in the chinchilla model, providing further evidence that peptides corresponding to sequences in the P5-fimbrin may be effective vaccine antigens.
70. Novotny L, Pichichero M, Denoel P, et al. Detection and characterization of pediatric serum antibody to the OMP P5-homologous adhesin of nontypeable Haemophilus influenzae during acute otitis media. Vaccine 2002; 20:3590-3597.
71. Hotomi M, Yamanaka N, Shimada J, et al. Intranasal immunization with recombinant outer membrane protein P6 induces specific immune responses against nontypeable Haemophilus influenzae. Int J Pediatr Otorhinolaryngol 2002; 65:109-116. This study showed that intranasal immunization with recombinant P6 protein induces protection from nasopharyngeal colonization in mice, providing further evidence that P6 may represent an effective vaccine antigen.
72. Hiltke TJ, Sethi S, Murphy TF. Sequence stability of the gene encoding outer membrane protein P2 of nontypeable Haemophilus influenzae in the human respiratory tract. J Infect Dis 2002; 185:627-631.
73. Cripps AW, Foxwell R, Kyd J. Challenges for the development of vaccines against Haemophilus influenzae and Neisseria meningitidis. Curr Opin Immunol 2002; 14:553-557.
74. Russell F, Mulholland K. Prevention of otitis media by vaccination. Drugs 2002; 62:1441-1445.
75. Greenberg DP, Hoberman A. Vaccine prevention of acute otitis media. Curr Allergy Asthma Rep 2001; 1:356-363.
76. Karma P. Vaccination and otitis media. ORL J Otorhinolaryngol Relat Spec 2002; 64:80-85.
77. Greenberg DP. Update on the development and use of viral and bacterial vaccines for the prevention of acute otitis media. Allergy Asthma Proc 2001; 22:353-357.